May 25, 2020 United we are stronger
Biopharmaceutical companies and contract development and manufacturing organizations (CDMO) worldwide are working side by side in the fight against the COVID-19 pandemic. Ultimately, it is these joint efforts that will pave the way out of this crisis - by mitigating life-threatening symptoms, reducing mortality rates, and developing effective vaccines. As a proven expert in the production of highly complex biopharmaceuticals, we at Rentschler Biopharma, are dedicated to ensuring a reliable supply of life-saving therapies - for the treatment of COVID-19 and beyond.
Dr. Cora Kaiser, Senior Director Corporate Communication and Wolfram Schuze, VP IT & Organisation and Head of Infection Prevention Task Force, share their thoughts on the potential that this crisis holds, to learn, optimize and develop together with and for our clients. Article in transkript (German only).
Rentschler Biopharma SE
Dr. Latika Bhonsle-Deeng
Senior Director Corporate Communication